肺癌中癌症相关胚系突变图谱的生物学与治疗意义
本综述总结了肺癌胚系易感性的研究现状。尽管吸烟是肺癌主要病因,但仅约15%的终身吸烟者患病,且相当比例肺癌发生于不吸烟者,提示遗传因素作用。家族史阳性者肺癌更常见,尤其早发疾病。常规临床引入二代测序使越来越多肺癌患者发现癌症易感突变,综述强调对肺癌患者进行胚系检测的重要性,以识别高危个体并指导个体化治疗及通过遗传咨询和筛查实现预防。
要点
- 仅约15%的终身吸烟者发生肺癌,不吸烟者肺癌占比可观,提示遗传易感性作用。
- 家族史阳性者肺癌风险显著升高,尤其早发肺癌。
- 常规二代测序可识别肺癌患者中的癌症易感胚系突变,支持胚系检测用于风险评估和个体化治疗。
核心结论
- 肺癌患者中胚系易感突变日益被识别,胚系检测有助于识别高危个体并指导个体化治疗与预防。
研究设计与样本
- 综述类文章,总结肺癌胚系易感性图谱并论述胚系检测在肺癌患者中的重要性。
主要发现
- 仅约15%的终身吸烟者发生肺癌,相当比例肺癌发生于不吸烟者。
- 家族史阳性者肺癌显著更常见,尤其早发疾病。
- 常规二代测序使越来越多肺癌患者发现癌症易感突变。
临床怎么用
- 对肺癌患者考虑胚系检测以识别遗传易感个体。
- 胚系检测结果可用于遗传咨询、筛查及个体化治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although smoking is the primary cause of lung cancer, only about 15% of lifelong smokers develop the disease. Moreover, a substantial proportion of lung cancer cases occur in never-smokers, highlighting the potential role of inherited genetic factors in the cause of lung cancer. Lung cancer is significantly more common among those with a positive family history, especially for early-onset disease. Therefore, the presence of pathogenic germline variants might act synergistically with environmental factors. The incorporation of next-generation sequencing in routine clinical practice has led to the identification of cancer-predisposing mutations in an increasing proportion of patients with lung cancer. This Review summarises the landscape of germline susceptibility in lung cancer and highlights the importance of germline testing in patients diagnosed with the disease, which has the potential to identify individuals at risk, with implications for tailored therapeutic approaches and successful prevention through genetic counselling and screening.
引用
- Panagiotou E, Vathiotis IA, Makrythanasis P, et al. Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer. Lancet Respir Med. 2024. PMID: 38885686. doi:10.1016/S2213-2600(24)00124-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。